Literature DB >> 9457284

Laparoscopic adrenalectomy: experience with transabdominal and retroperitoneal approaches.

C Chee1, T Ravinthiran, C Cheng.   

Abstract

OBJECTIVES: To study the patient outcomes of various approaches on 14 consecutive patients who had laparoscopic adrenalectomy surgery between October 1995 and March 1997.
METHODS: The patients comprised 5 men and 9 women (mean age 46.2 years, range 32 to 61) with varying diagnoses. Eleven patients had Conn's syndrome, 1 had Cushing's syndrome, 1 had a nonfunctioning adrenal adenoma, and 1 had an adrenal myelolipoma. The adenomas were confirmed by hormonal assays, biochemical tests, and computed tomography (CT) imaging. Seven adenomas were sited on the right and seven were sited on the left. We used two alternative approaches: a transabdominal approach (8 patients) and a retroperitoneal approach (6 patients).
RESULTS: None of the procedures required conversion to open surgery, nor was there any procedure-related complication. Blood loss was minimal. All the lesions were benign on final histology. The mean operating time was 135 minutes (range 80 to 190). The postoperative period was without significant complications, with patients reporting minimal pain. Patients were able to achieve an early return to oral intake and preoperative activity. The postoperative hospital period ranged from 1 to 10 days.
CONCLUSIONS: We believe laparoscopic adrenalectomy to be a viable option in the removal of benign adrenal lesions. It is a safe technique when performed by experienced practitioners and results in faster recovery. The key advantage to this technique is its minimally invasive approach and decreased hospital costs.

Entities:  

Mesh:

Year:  1998        PMID: 9457284     DOI: 10.1016/s0090-4295(97)00468-8

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  8 in total

1.  The influence of new technologies on laparoscopic adrenalectomy: our personal experience with 91 patients.

Authors:  A Valeri; A Borrelli; L Presenti; M Lucchese; G Manca; P Tonelli; C Bergamini; D Borrelli; M Palli; C Saieva
Journal:  Surg Endosc       Date:  2002-05-07       Impact factor: 4.584

Review 2.  Evaluation of endoscopic and traditional open approaches to pheochromocytoma.

Authors:  A M Kazaryan; N S Kuznetsov; A M Shulutko; D G Beltsevich; B Edwin
Journal:  Surg Endosc       Date:  2004-04-27       Impact factor: 4.584

Review 3.  Evaluation of Open and Minimally Invasive Adrenalectomy: A Systematic Review and Network Meta-analysis.

Authors:  Patrick Heger; Pascal Probst; Felix J Hüttner; Käthe Gooßen; Tanja Proctor; Beat P Müller-Stich; Oliver Strobel; Markus W Büchler; Markus K Diener
Journal:  World J Surg       Date:  2017-11       Impact factor: 3.352

4.  Laparoscopic adrenalectomy in children.

Authors:  E Mirallié; M D Leclair; P de Lagausie; D Weil; V Plattner; C Duverne; A DeWint; G Podevin; Y Héloury
Journal:  Surg Endosc       Date:  2001-02       Impact factor: 4.584

5.  Transperitoneal laparoscopic adrenalectomy for metachronous contralateral adrenal metastasis from renal cell carcinoma: a case report.

Authors:  Evangelos Zacharakis; Maria J Ribal; Emmanouil Zacharakis; Hiten Rh Patel
Journal:  Cases J       Date:  2008-09-26

6.  Retroperitoneoscopic or laparoscopic adrenalectomy? A single-centre UK experience.

Authors:  Vasilis A Constantinides; Ioannis Christakis; Philip Touska; Karim Meeran; Fausto Palazzo
Journal:  Surg Endosc       Date:  2013-05-25       Impact factor: 4.584

7.  Safe retroperitoneal endoscopic resection of pheochromocytomas.

Authors:  Frits J Berends; Erwin Van Der Harst; Giuseppe Giraudo; Türkan Terkivatan; Geert Kazemier; Hajo A Bruining; Wouter W De Herder; H Jaap Bonjer
Journal:  World J Surg       Date:  2002-03-01       Impact factor: 3.352

8.  Outcome of patients undergoing laparoscopic adrenalectomy for primary hyperaldosteronism.

Authors:  Brian K P Goh; Yeh-Hong Tan; Sidney K H Yip; Peter H K Eng; Christopher W S Cheng
Journal:  JSLS       Date:  2004 Oct-Dec       Impact factor: 2.172

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.